Maze Therapeutics, Inc.
MAZE
$7.83
$0.233.03%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 196.81M | 149.61M | 175.07M | 175.07M | 29.16M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.86M | 4.25M | 4.33M | 4.33M | 4.95M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 100.00K | -- | -- | -- |
| Total Current Assets | 201.67M | 153.96M | 179.40M | 179.40M | 34.11M |
|
|
|||||
| Total Current Assets | 201.67M | 153.96M | 179.40M | 179.40M | 34.11M |
| Net Property, Plant & Equipment | 29.92M | 30.93M | 32.17M | 32.17M | 34.98M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.95M | 7.59M | 4.23M | 4.23M | 2.41M |
| Total Assets | 240.54M | 192.48M | 215.79M | 215.79M | 71.50M |
|
|
|||||
| Total Accounts Payable | 1.94M | 1.02M | 2.18M | 2.18M | 2.02M |
| Total Accrued Expenses | 14.10M | 11.70M | 10.62M | 10.62M | 9.81M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.63M | 4.62M | 4.57M | 4.57M | 4.49M |
| Total Finance Division Other Current Liabilities | -- | 217.00K | 4.23M | 4.23M | -- |
| Total Other Current Liabilities | -- | 217.00K | 4.23M | 4.23M | -- |
| Total Current Liabilities | 20.67M | 17.56M | 21.61M | 21.61M | 16.32M |
|
|
|||||
| Total Current Liabilities | 20.67M | 17.56M | 21.61M | 21.61M | 16.32M |
| Long-Term Debt | -- | 51.75M | 49.10M | 49.10M | 20.08M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 22.00M | 22.80M | 23.56M | 23.56M | 25.05M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 969.00K | 1.01M | -- | -- | -- |
| Total Liabilities | 43.64M | 93.11M | 94.27M | 94.27M | 61.45M |
|
|
|||||
| Common Stock & APIC | 47.24M | 29.34M | 26.75M | 26.75M | 21.84M |
| Retained Earnings | -358.43M | -313.88M | -289.12M | -289.12M | -395.69M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -311.18M | -284.53M | -262.37M | -262.37M | -373.85M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 508.09M | 383.90M | 383.90M | 383.90M | 383.90M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 508.09M | 383.90M | 383.90M | 383.90M | 383.90M |
|
|
|||||
| Total Common Equity | -311.18M | -284.53M | -262.37M | -262.37M | -373.85M |
| Total Preferred Equity | 508.09M | 383.90M | 383.90M | 383.90M | 383.90M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 196.90M | 99.37M | 121.53M | 121.53M | 10.05M |
|
|
|||||